Genentech
PULMOZYME
Manufacturer:
Genentech
Name:
PULMOZYME
HCPCS Code Descriptor:
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Category:
J Code
HCPCS:
J7639
NDC(s):
50242-0100-40
Primary Type:
Pulmonary
Generic Status:
Single-Source
Route of Administration:
Inhalation
About:
PULMOZYME is a Pulmonary drug manufactured by Genentech and administered via the Inhalation route of administration. The J Code: J7639 is aligned to the drug PULMOZYME.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/00
HCPCS Effective Date:
1/1/09
HCPCS Short Description:
Dornase alfa non-comp unit
Billing and Coding Guide:
https://www.pulmozyme.com/content/dam/gene/accesssolutions/pdfs/coding/Pulmozyme-Billing-Coding-for-Cystic-Fibrosis.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation